Cargando…
A COL4A5 mutation with glomerular disease and signs of chronic thrombotic microangiopathy
COL4A5 mutations are a known cause of Alport syndrome, which typically manifests with haematuria, hearing loss and ocular symptoms. Here we report on a 16-year-old male patient with a negative family history who presented with proteinuria, progressive renal failure and haemolysis, but without overt...
Autores principales: | Wuttke, Matthias, Seidl, Maximilian, Malinoc, Angelica, Prischl, Friedrich C., Kuehn, E. Wolfgang, Walz, Gerd, Köttgen, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655797/ https://www.ncbi.nlm.nih.gov/pubmed/26613025 http://dx.doi.org/10.1093/ckj/sfv091 |
Ejemplares similares
-
Thrombotic microangiopathy associated with proteasome inhibitors
por: Lodhi, Ahad, et al.
Publicado: (2015) -
Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome
por: Thomas, Christie P., et al.
Publicado: (2015) -
Thrombotic microangiopathy: expanding genetic, clinical and therapeutic spectra and the need for worldwide implementation of recent advances
por: Sanchez-Niño, Maria D., et al.
Publicado: (2015) -
Chapter 2: General principles in the management of glomerular disease
Publicado: (2012) -
Chapter 14: Anti-glomerular basement membrane antibody glomerulonephritis
Publicado: (2012)